查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146920

聚氨酯植入式醫療設備市場：全球市場預測，2026-2032年

Polyurethane Implantable Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，聚氨酯植入式醫療設備市場規模將成長至 39.6 億美元，複合年成長率為 7.79%。

主要市場統計數據
基準年 2025 23.4億美元
預計年份：2026年 25.2億美元
預測年份 2032 39.6億美元
複合年成長率 (%) 7.79%

聚氨酯植入式醫療設備：概述

聚氨酯植入式醫療設備採用特殊設計的聚合物，適用於對柔軟性、彈性、耐久性和生物相容性要求極高的應用領域。相關產品應用於軟組織、心血管、整形外科、泌尿系統、神經科和藥物傳遞等領域。其臨床價值取決於器械的具體設計、植入技術、滅菌過程以及與周圍組織的長期相互作用。市場發展受患者安​​全要求、監管證據、生產一致性以及在真實臨床環境中驗證其持久性能的需求等因素的影響。

設計、法規和材料正在重塑醫療設備。

行業趨勢正朝著應用特定的聚氨酯配方、改進的表面工程以及更嚴格的機械性能控制方向發展。研發人員更重視在維持每種適應症所需的柔軟性和韌性的同時，最大限度地降低發炎、劣化、血栓形成、感染風險和醫療設備失效的風險。監管機構越來越重視材料表徵與臨床結果、生命週期監測、可追溯性和上市後監管的相關性。這些壓力要求嚴格的設計控制、檢驗的生產流程以及涵蓋即時性能和長期安全性的證據包。

人工智慧 (AI) 可提升設計、品質和臨床證據工作流程。

人工智慧 (AI) 可透過識別配方、加工條件、機械性能和生物反應性之間的關係，輔助開發聚氨酯植入式醫療設備。機器學習工具可以幫助改善實驗優先順序、檢測生產異常、分析影像資料和病患記錄以及監測不利事件。其價值仍然依賴具有代表性的數據、透明的驗證、網路安全和人工監督。在受監管的環境中，AI 產生的見解必須與已記錄的要求、可重複的方法和具有臨床意義的終點相關聯，而不能被視為實驗室、動物或人體證據的替代品。

北美、拉丁美洲、歐洲、中東和非洲以及亞太地區的優先事項各不相同。

在北美，重點在於先進的臨床證據、精湛的製造技術以及詳盡的法規和報銷要求。在歐洲，除了嚴格的醫療設備監管體系外，還注重生物相容性、永續性和上市後證據。亞太地區受益於不斷擴展的醫療保健體系、先進的製造能力以及對專業植入日益成長的需求，但各地區的監管路徑和准入條件差異顯著。在拉丁美洲，人們看到了改善外科手術可近性所帶來的機遇，但需要仔細考慮進口程序、報銷限制和基礎設施差異等問題。在中東，醫療保健現代化和對專科醫療的投資正在推進，各國在採購和在地化方面的優先事項各不相同。非洲的情況仍然高度多樣化，產品滲透率受多種因素影響，例如價格承受能力、外科手術體系、供應穩定性以及訓練有素的臨床醫生數量。

東協、金磚國家、歐盟、七國集團、海灣合作理事會和北約各自反映了不同的產業狀況。

東協市場在監管成熟度、醫療基礎設施和對進口醫療設備的依賴程度方面存在差異，因此區域間的協調和分銷能力至關重要。金磚國家擁有龐大且多元化的患者群體，並有意願在國內生產醫療器械，但在醫療服務取得、報銷和監管要求方面仍存在差異。歐盟高度重視合格評定、臨床文件、化學品安全和生命週期監測。七國集團（G7）國家通常擁有先進的研發、臨床和品管體系，但也以嚴格的證據要求為特徵。海灣合作理事會（GCC）市場以集中採購、對專業醫療領域的投資和在地化努力為特徵。雖然北約成員國並非單一的監管集團，但它們在供應鏈韌性、緊急準備和高可靠性醫療技術方面的通用利益可能會影響其採購和生產的優先事項。

每個國家的實際情況決定了其獲取途徑、證據和生產策略。

澳洲擁有完善的臨床體系和地域分散的醫療服務結構。巴西和墨西哥需要考慮公共和私營醫療管道、當地監管程序以及分銷網路的覆蓋範圍。加拿大強調實證醫學、省級准入途徑和供應可靠性。中國、印度、日本和韓國擁有相當的臨床和生產能力，但每個國家都有其獨特的核准、報銷和本地化要求。法國、德國、義大利和西班牙均在歐盟框架內運作，但在採購、醫院組織和臨床部署模式方面存在差異。英國維持著自身的監管和醫療技術環境，需要製定在地化的實證醫學和准入計畫。俄羅斯在監管管理、供應連續性和地緣政治限制方面還有其他需要考慮的因素。在美國，醫療設備分類、上市前證據、品質系統、編碼、保險覆蓋範圍和長期監測尤其重要。

優先考慮生物相容性、證據品質、穩健的生產系統和負責任的人工智慧。

產業領導者應根據​​臨床適應症和風險狀況對研發項目進行細分，而不是將聚氨酯視為單一材料類別。他們還應儘早進行生物相容性、劣化、機械疲勞、無菌性和萃取物/浸出物測試，使材料規格與臨床使用條件相匹配，並將上市後監測納入產品規劃。市場准入順序應根據區域監管環境、臨床醫生和患者的回饋以及醫保報銷情況來確定。生產策略應包括選擇合格供應商、實施切實可行的雙重採購、製程監控和嚴格的變更控管程序。在實施人工智慧時，初期重點應放在檢驗的高價值工作流程上，並確保責任明確、審計追蹤、資料管治和網路安全措施到位。

調查方法：對檢驗的產業證據進行結構化整合

本執行摘要基於聚氨酯植入式醫療設備的定性綜合框架。此方法需要交叉引用和分析同行評審的生物醫學文獻、監管指南和公開評估資料、臨床試驗記錄、生物學評估和品管相關標準、安全資訊、醫院和採購文件，以及（如適用）公開的貿易和政策資訊來源。應仔細檢視研究結果的資訊來源可靠性、發表日期、地理相關性和針對特定器械的適用性。結論應分為已確立的證據、新興實踐和未解決的問題，且結論應僅限於可獨立檢驗的資訊。本摘要不使用市場估算、預測、市場佔有率、預測結果或公司特定聲明。

長期成功取決於以臨床證據為基礎並根據當地情況進行調整的實施方案。

聚氨酯植入式醫療設備仍然是一個跨學科領域，與材料科學、臨床實踐、監管、生產製造和患者獲取密切相關。要取得進展，需要持續證明其在特定適應症中的安全性和有效性，提高生產製造的可重複性，並根據當地和國家實際情況調整證據和商業化計劃。雖然人工智慧 (AI) 可以加速某些環節，但負責任的管治和臨床檢驗仍然至關重要。那些能夠將嚴謹的生命週期證據、穩健的營運結構和切實可行的獲取策略相結合的領導者，將更有能力把聚氨酯領域的創新轉化為可靠的病患治療效果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：聚氨酯植入式醫療設備市場：依產品類型分類

  • 心臟導線
    • 去心房顫動導線
    • 領跑者
  • 導管
    • 動脈導管
    • 靜脈導管
  • 組織框架
  • 血管移植
    • 生物移植
    • 合成接枝

第8章：聚氨酯植入式醫療設備市場：依材料類型分類

  • 聚酯聚氨酯
  • 聚醚聚氨酯
  • 熱塑性聚氨酯
  • 熱固性聚氨酯

第9章：聚氨酯植入式醫療設備市場：依植入期分類

  • 永恆的
  • 暫時的

第10章：聚氨酯植入式醫療設備市場：依應用領域分類

  • 心血管系統
    • 電生理學
    • 介入治療
  • 神經系統
  • 眼科
  • 整形外科
  • 泌尿系統

第11章：聚氨酯植入式醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專業醫療中心

第12章：聚氨酯植入式醫療設備市場：依分銷管道分類

  • 直銷
  • 銷售代理
  • 線上銷售

第13章：聚氨酯植入式醫療設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：聚氨酯植入式醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：聚氨酯植入式醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Rochester Medical Corporation
  • Teleflex Incorporated
  • Terumo Corporation

第18章 主要專家

Product Code: MRR-3D150775E4A2

The Polyurethane Implantable Devices Market is projected to grow by USD 3.96 billion at a CAGR of 7.79% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.34 billion
Estimated Year [2026] USD 2.52 billion
Forecast Year [2032] USD 3.96 billion
CAGR (%) 7.79%

Polyurethane Implantable Devices: Executive Overview

Polyurethane implantable devices use engineered polymers in applications where flexibility, elasticity, durability, and biocompatibility are important. Relevant products span soft-tissue, cardiovascular, orthopedic, urological, neurological, and drug-delivery applications. Clinical value depends on device-specific design, implantation technique, sterilization, and long-term interaction with surrounding tissue. Market development is shaped by patient safety requirements, regulatory evidence, manufacturing consistency, and the need to demonstrate durable performance in real-world use.

Design, Regulation, and Materials Are Reshaping Device Development

The landscape is shifting toward application-specific polyurethane formulations, improved surface engineering, and tighter control of mechanical properties. Developers are placing greater emphasis on minimizing inflammation, degradation, thrombogenicity, infection risk, and device failure while preserving the flexibility or toughness required by each indication. Regulatory expectations increasingly connect material characterization with clinical outcomes, lifecycle monitoring, traceability, and post-market surveillance. These pressures favor disciplined design controls, validated processing, and evidence packages that address both immediate performance and long-term safety.

Artificial Intelligence Strengthens Design, Quality, and Clinical Evidence Workflows

Artificial intelligence can support polyurethane implantable-device development by identifying relationships among formulation, processing conditions, mechanical performance, and biological response. Machine-learning tools may help prioritize experiments, detect manufacturing anomalies, analyze imaging and patient records, and improve monitoring of adverse events. Their value remains dependent on representative data, transparent validation, cybersecurity, and human oversight. In regulated settings, AI-generated insights must be linked to documented requirements, reproducible methods, and clinically meaningful endpoints rather than treated as a substitute for laboratory, animal, or human evidence.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America emphasizes advanced clinical evidence, sophisticated manufacturing, and detailed regulatory and reimbursement requirements. Europe combines stringent device oversight with strong attention to biocompatibility, sustainability, and post-market evidence. Asia-Pacific is supported by expanding healthcare capacity, advanced manufacturing capabilities, and growing demand for specialized implants, while regulatory pathways and access conditions vary considerably. Latin America presents opportunities linked to improving surgical access but requires careful navigation of import procedures, reimbursement limitations, and uneven infrastructure. The Middle East is investing in healthcare modernization and specialist care, with procurement and localization priorities varying by country. Africa remains diverse, with adoption influenced by affordability, surgical capacity, supply continuity, and the availability of trained clinicians.

ASEAN, BRICS, European Union, G7, GCC, and NATO Reflect Distinct Industry Conditions

ASEAN markets differ in regulatory maturity, healthcare infrastructure, and dependence on imported devices, making regional harmonization and distribution capability important. BRICS economies combine large and diverse patient populations with domestic manufacturing ambitions, but access, reimbursement, and regulatory requirements remain uneven. The European Union places strong emphasis on conformity assessment, clinical documentation, chemical safety, and lifecycle surveillance. G7 countries generally have advanced research, clinical, and quality systems, alongside demanding evidence expectations. GCC markets are shaped by centralized procurement, specialist healthcare investment, and localization initiatives. NATO countries are not a single regulatory bloc, but shared attention to supply resilience, emergency preparedness, and high-reliability medical technologies can influence procurement and manufacturing priorities.

Country Conditions Shape Access, Evidence, and Manufacturing Strategy

Australia combines established clinical systems with geographically dispersed care delivery. Brazil and Mexico require attention to public and private healthcare channels, local regulatory procedures, and distribution reach. Canada emphasizes evidence, provincial access pathways, and supply reliability. China, India, Japan, and South Korea offer substantial clinical and manufacturing capabilities, while each has distinct approval, reimbursement, and localization requirements. France, Germany, Italy, and Spain operate within the European Union framework but differ in procurement, hospital organization, and clinical adoption patterns. The United Kingdom maintains its own regulatory and health-technology environment, requiring locally relevant evidence and access planning. Russia presents additional considerations involving regulatory administration, supply continuity, and geopolitical constraints. The United States places particular weight on device classification, premarket evidence, quality systems, coding, coverage, and long-term surveillance.

Prioritize Biocompatibility, Evidence Quality, Resilient Production, and Responsible AI

Industry leaders should segment development programs by clinical indication and risk profile rather than treating polyurethane as a uniform material category. They should establish early biocompatibility, degradation, mechanical-fatigue, sterilization, and extractables-and-leachables testing; align material specifications with clinical use conditions; and build post-market surveillance into product planning. Regional regulatory mapping, clinician and patient input, and reimbursement evidence should guide launch sequencing. Manufacturing strategies should include qualified suppliers, dual sourcing where practical, process monitoring, and strict change-control procedures. AI adoption should focus first on validated, high-value workflows with clear accountability, audit trails, data governance, and cybersecurity controls.

Methodology: Structured Synthesis of Verified Industry Evidence

This executive summary is based on a qualitative synthesis framework for polyurethane implantable devices. The approach should triangulate peer-reviewed biomedical literature, regulatory guidance and public assessment materials, clinical-trial records, standards relevant to biological evaluation and quality management, safety communications, hospital and procurement documentation, and public trade or policy sources where applicable. Findings should be screened for source reliability, publication date, geographic relevance, and device-specific applicability. Claims should be separated into established evidence, emerging practice, and unresolved questions, with conclusions limited to information that can be independently verified. No market estimates, market shares, forecasts, or company-specific claims are used.

Long-Term Success Depends on Clinically Grounded, Regionally Adapted Execution

Polyurethane implantable devices remain a multidisciplinary field in which material science, clinical practice, regulation, manufacturing, and patient access are tightly connected. Progress will depend on demonstrating durable safety and performance for defined indications, improving manufacturing reproducibility, and adapting evidence and commercialization plans to regional and country-level conditions. Artificial intelligence can accelerate selected activities, but responsible governance and clinical validation remain essential. Leaders that combine rigorous lifecycle evidence with resilient operations and practical access strategies will be better positioned to translate polyurethane innovations into dependable patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Polyurethane Implantable Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Cardiac Leads
    • 7.2.1. Defibrillator Leads
    • 7.2.2. Pacemaker Leads
  • 7.3. Catheters
    • 7.3.1. Arterial Catheters
    • 7.3.2. Venous Catheters
  • 7.4. Tissue Scaffolds
  • 7.5. Vascular Grafts
    • 7.5.1. Biological Grafts
    • 7.5.2. Synthetic Grafts

8. Polyurethane Implantable Devices Market, by Material Type

  • 8.1. Introduction
  • 8.2. Polyester Polyurethane
  • 8.3. Polyether Polyurethane
  • 8.4. Thermoplastic Polyurethane
  • 8.5. Thermoset Polyurethane

9. Polyurethane Implantable Devices Market, by Implant Duration

  • 9.1. Introduction
  • 9.2. Permanent
  • 9.3. Temporary

10. Polyurethane Implantable Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Cardiovascular
    • 10.2.1. Electrophysiology
    • 10.2.2. Interventional Procedures
  • 10.3. Neurological
  • 10.4. Ophthalmic
  • 10.5. Orthopedic
  • 10.6. Urological

11. Polyurethane Implantable Devices Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Clinics
  • 11.4. Hospitals
    • 11.4.1. Private Hospitals
    • 11.4.2. Public Hospitals
  • 11.5. Specialty Centers

12. Polyurethane Implantable Devices Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Direct Sales
  • 12.3. Distributors
  • 12.4. Online Sales

13. Polyurethane Implantable Devices Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Polyurethane Implantable Devices Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Polyurethane Implantable Devices Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. B. Braun Melsungen AG
  • 17.3. Baxter International Inc.
  • 17.4. Becton, Dickinson and Company
  • 17.5. Boston Scientific Corporation
  • 17.6. Edwards Lifesciences Corporation
  • 17.7. Johnson & Johnson
  • 17.8. Medtronic plc
  • 17.9. Rochester Medical Corporation
  • 17.10. Teleflex Incorporated
  • 17.11. Terumo Corporation

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Polyurethane Implantable Devices Market, Years Considered for the Study
  • FIGURE 2. Global Polyurethane Implantable Devices Market, Research Design
  • FIGURE 3. Global Polyurethane Implantable Devices Market, Research Framework
  • FIGURE 4. Global Polyurethane Implantable Devices Market, Data Triangulation
  • FIGURE 5. Global Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Polyurethane Implantable Devices Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Polyurethane Implantable Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Polyurethane Implantable Devices Market Size, by Material Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Polyurethane Implantable Devices Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Polyurethane Implantable Devices Market Size, by Implant Duration, 2025 vs 2032 (%)
  • FIGURE 11. Global Polyurethane Implantable Devices Market Size, by Implant Duration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Polyurethane Implantable Devices Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global Polyurethane Implantable Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Polyurethane Implantable Devices Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Polyurethane Implantable Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Polyurethane Implantable Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 17. Global Polyurethane Implantable Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Polyurethane Implantable Devices Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Polyurethane Implantable Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Polyurethane Implantable Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Polyurethane Implantable Devices Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Polyurethane Implantable Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Polyurethane Implantable Devices Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Polyurethane Implantable Devices Market Segmentation & Coverage
  • TABLE 2. Global Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Cardiac Leads Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Cardiac Leads Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Cardiac Leads Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Defibrillator Leads Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Defibrillator Leads Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Defibrillator Leads Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Pacemaker Leads Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Pacemaker Leads Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Pacemaker Leads Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Catheters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Catheters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Catheters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Arterial Catheters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Arterial Catheters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Arterial Catheters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Venous Catheters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Venous Catheters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Venous Catheters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Tissue Scaffolds Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Tissue Scaffolds Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Tissue Scaffolds Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Vascular Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Vascular Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Vascular Grafts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Biological Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Biological Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Biological Grafts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Synthetic Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Synthetic Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Synthetic Grafts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 35. Global Polyester Polyurethane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Polyester Polyurethane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Polyester Polyurethane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Polyether Polyurethane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Polyether Polyurethane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Polyether Polyurethane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Thermoplastic Polyurethane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Thermoplastic Polyurethane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Thermoplastic Polyurethane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Thermoset Polyurethane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Thermoset Polyurethane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Thermoset Polyurethane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 48. Global Permanent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Permanent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Permanent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Temporary Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Temporary Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Temporary Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 55. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Electrophysiology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Electrophysiology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Electrophysiology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Interventional Procedures Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Interventional Procedures Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Interventional Procedures Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Neurological Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Neurological Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Neurological Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Ophthalmic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Ophthalmic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Ophthalmic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Orthopedic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Orthopedic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Orthopedic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Urological Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Urological Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Urological Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 77. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global Specialty Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Specialty Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Specialty Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 96. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 97. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 98. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 99. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 102. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 104. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 105. Global Polyurethane Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Asia-Pacific Polyurethane Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 107. Asia-Pacific Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 113. Asia-Pacific Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 114. Asia-Pacific Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 115. Asia-Pacific Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 116. Asia-Pacific Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 117. Asia-Pacific Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 118. North America Polyurethane Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 119. North America Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 120. North America Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 121. North America Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 122. North America Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 123. North America Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 124. North America Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 125. North America Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 126. North America Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 127. North America Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 128. North America Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 129. North America Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 130. Latin America Polyurethane Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Latin America Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 132. Latin America Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 133. Latin America Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 134. Latin America Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 135. Latin America Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 136. Latin America Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 137. Latin America Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 138. Latin America Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 139. Latin America Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 140. Latin America Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 141. Latin America Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 142. Europe Polyurethane Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 143. Europe Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 144. Europe Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 145. Europe Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 146. Europe Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 147. Europe Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 148. Europe Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 149. Europe Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 150. Europe Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 151. Europe Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 152. Europe Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 153. Europe Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 154. Middle East Polyurethane Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 155. Middle East Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 156. Middle East Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 157. Middle East Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 158. Middle East Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 159. Middle East Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 160. Middle East Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 161. Middle East Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 162. Middle East Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 163. Middle East Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 164. Middle East Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 165. Middle East Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 166. Africa Polyurethane Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 167. Africa Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 168. Africa Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 169. Africa Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 170. Africa Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 171. Africa Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 172. Africa Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 173. Africa Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 174. Africa Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 175. Africa Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 176. Africa Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 177. Africa Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 178. Global Polyurethane Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. ASEAN Polyurethane Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 180. ASEAN Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 181. ASEAN Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 182. ASEAN Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 183. ASEAN Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 184. ASEAN Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 185. ASEAN Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 186. ASEAN Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 187. ASEAN Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 188. ASEAN Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. ASEAN Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 190. ASEAN Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 191. GCC Polyurethane Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 192. GCC Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 193. GCC Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 194. GCC Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 195. GCC Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 196. GCC Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 197. GCC Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 198. GCC Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 199. GCC Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 200. GCC Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 201. GCC Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 202. GCC Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 203. European Union Polyurethane Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 204. European Union Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 205. European Union Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 206. European Union Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 207. European Union Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 208. European Union Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 209. European Union Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 210. European Union Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 211. European Union Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 212. European Union Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 213. European Union Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 214. European Union Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 215. BRICS Polyurethane Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 216. BRICS Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 217. BRICS Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 218. BRICS Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 219. BRICS Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 220. BRICS Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 221. BRICS Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 222. BRICS Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 223. BRICS Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 224. BRICS Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 225. BRICS Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 226. BRICS Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 227. G7 Polyurethane Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 228. G7 Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 229. G7 Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 230. G7 Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 231. G7 Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 232. G7 Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 233. G7 Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 234. G7 Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 235. G7 Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 236. G7 Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 237. G7 Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 238. G7 Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 239. NATO Polyurethane Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 240. NATO Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 241. NATO Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 242. NATO Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 243. NATO Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 244. NATO Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 245. NATO Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 246. NATO Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 247. NATO Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 248. NATO Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 249. NATO Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 250. NATO Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 251. Global Polyurethane Implantable Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 252. United States Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 253. United States Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 254. United States Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 255. United States Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 256. United States Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 257. United States Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 258. United States Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 259. United States Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 260. United States Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 261. United States Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 262. United States Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 263. United States Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 264. Canada Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 265. Canada Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 266. Canada Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 267. Canada Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 268. Canada Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 269. Canada Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 270. Canada Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 271. Canada Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 272. Canada Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 273. Canada Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 274. Canada Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 275. Canada Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 276. Mexico Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 277. Mexico Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 278. Mexico Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 279. Mexico Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 280. Mexico Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 281. Mexico Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 282. Mexico Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 283. Mexico Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 284. Mexico Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 285. Mexico Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 286. Mexico Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 287. Mexico Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 288. Brazil Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 289. Brazil Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 290. Brazil Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 291. Brazil Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 292. Brazil Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 293. Brazil Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 294. Brazil Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 295. Brazil Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 296. Brazil Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 297. Brazil Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 298. Brazil Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 299. Brazil Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 300. United Kingdom Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 301. United Kingdom Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 302. United Kingdom Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 303. United Kingdom Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 304. United Kingdom Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 305. United Kingdom Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 306. United Kingdom Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 307. United Kingdom Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 308. United Kingdom Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 309. United Kingdom Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 310. United Kingdom Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 311. United Kingdom Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 312. Germany Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 313. Germany Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 314. Germany Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 315. Germany Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 316. Germany Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 317. Germany Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 318. Germany Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 319. Germany Polyurethane Implantable Devices Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 320. Germany Polyurethane Implantable Devices Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 321. Germany Polyurethane Implantable Devices Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 322. Germany Polyurethane Implantable Devices Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 323. Germany Polyurethane Implantable Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 324. France Polyurethane Implantable Devices Market Size, 2017-2032 (USD Million)
  • TABLE 325. France Polyurethane Implantable Devices Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 326. France Polyurethane Implantable Devices Market Size, by Cardiac Leads, 2017-2032 (USD Million)
  • TABLE 327. France Polyurethane Implantable Devices Market Size, by Catheters, 2017-2032 (USD Million)
  • TABLE 328. France Polyurethane Implantable Devices Market Size, by Vascular Grafts, 2017-2032 (USD Million)
  • TABLE 329. France Polyurethane Implantable Devices Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 330. France Polyurethane Implantable Devices Market Size, by Implant Duration, 2017-2032 (USD Million)
  • TABLE 331. France Polyurethane Implanta